Manulife expanding its list of generic drugs for Quebec
This applies to plan sponsors with a generic substitution plan and plan members who are residents of Quebec.
On May 2, Manulife will add more drugs to its current list of generics for Quebec.
This means that for Manulife plans with members in Quebec that have a generic substitution clause and a drug card, reimbursement will be limited to the price of these newly listed generics when the member purchases the brand name equivalent.
Previously, Manulife’s list of generics for Quebec only included those with a brand name equivalent on the RAMQ formulary. However, pharmacists in the province are allowed to switch a brand name prescription to a generic even if the generic is not listed on RAMQ. Manulife is now taking the opportunity to maximize your potential savings.
Some of the most commonly used brand name drugs that will be affected are listed below.
- ACTONEL 150MG TAB
- ANAPROX 275MG & DOUBLE STRENGTH 550MG TAB
- ASPIRIN 325MG TAB, 81MG QUICK CHEW TAB & ENTERIC COATED 81MG TAB
- ATACAND 4MG TAB
- ATIVAN 0.5/1/2 MG SUBLINGUAL TAB
- ATROVENT 0.06% NASAL SPR AY
- BENTYLOL 10MG/20MG TAB
- CIPRALEX 10MG/20MG TAB
- DIANE-35 TAB
- FIORINAL REG & C1/2 & C1/4 CAP
- IMOVANE 5/7.5MG TAB
- PALAFER 300MG CAP
- PANTOLOC 20MG TAB
- PENNSAID 1.5% TOPICAL SOLUTION
- REACTINE 10/20MG TAB
- RITALIN 10MG TAB
- TRAMACET 37.5/325MG TAB
- ULTRAM 50MG TAB
- SUBLINOX 10MG/5MG TAB
- TENORETIC 100/25MG & 50/25MG TAB
Will this affect the plan member experience?
New generic drugs are introduced to the market and added to provincial formularies on a regular basis. When this happens, pharmacists are usually automatically prompted to make the switch to the generic without the member going back to their doctor. Plan members will have the same experience for these new drugs being added to the list. Their pharmacist will be prompted and reimbursement will be limited to the cost of the generic drug.
Communicating with your employees
We’ve created a plan member communication. Feel free to share this with your employees to help educate them about how this update may affect them.